Anti-Human CGRP Therapeutic Antibody (Fremanezumab)

Recombinant monoclonal antibody to CGRP. Fremanezumab is a humanized monoclonal antibody that can be potentially used in the treatment of Migraine. It binds to and inhibits the activity of CGRP.
Supplier Creative Biolabs
Product # TAB-428CQ
Pricing Inquiry
Host Human
Target CGRP
Species Reactivity Human
Type IgG2, κ
Applications ELISA, IHC, FC, IP, IF, Inhib, FuncS
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback